This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Trump Administration Cancels Moderna...
Regulatory funding cancellation

Trump Administration Cancels Moderna Vaccine Funding

Analysis based on 6 articles · First reported May 29, 2025 · Last updated May 29, 2025

Sentiment
-20
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The cancellation of $766 million in funding by the United States — United States Department of Health and Human Services for Moderna's pandemic influenza vaccine creates uncertainty for Moderna's stock and future vaccine development. This decision, influenced by Robert F. Kennedy Jr.'s skepticism, could also impact public health preparedness in the United States against potential pandemics.

Biotechnology Pharmaceuticals
Event Summary

The Donald Trump administration, through the United States — United States Department of Health and Human Services, canceled $766 million in funding previously awarded to Moderna for the development of its mRNA-1018 vaccine against potential pandemic influenza viruses, including H5N1 bird flu. This decision came despite Moderna announcing positive interim results from an early-stage trial of the vaccine. Health Secretary Robert F. Kennedy Jr.'s skepticism about mRNA vaccines is cited as a contributing factor. Moderna's CEO, Stéphane Bancel, expressed disappointment but affirmed the company's commitment to exploring alternative funding. Public health experts like Ashish Jha have criticized the move, warning of potential risks to American lives.

Key Actions
100 United States — United States Department of Health and Human Services canceled funding Moderna
70 Moderna announced positive results
60 Robert F. Kennedy Jr. said MMR vaccine is effective
Entities Involved
stock
Moderna
Moderna had $766 million in funding for its mRNA-1018 vaccine canceled by the United States — United States Department of Health and Human Services, adding uncertainty to the vaccine's development.
Importance 100.0 Sentiment -40.0
govactor
United States — United States Department of Health and Human Services
The United States — United States Department of Health and Human Services withdrew $766 million in funding from Moderna for the development of its mRNA-1018 vaccine.
Importance 90.0 Sentiment -20.0
per
Robert F. Kennedy Jr.
Robert F. Kennedy Jr., as Health Secretary, expressed deep skepticism regarding mRNA vaccines, which influenced the decision to cancel funding for Moderna's vaccine.
Importance 70.0 Sentiment -30.0
govactor
United States — Biomedical Advanced Research and Development Authority
The United States — Biomedical Advanced Research and Development Authority was the program through which the funds were initially awarded to Moderna for vaccine development.
Importance 60.0 Sentiment 0.0
per
Stéphane Bancel
Stéphane Bancel, CEO of Moderna, expressed disappointment over the funding termination but highlighted the positive interim results of the vaccine trial and the company's intent to explore alternative funding.
Importance 30.0 Sentiment -10.0
per
Ashish Jha
Ashish Jha, a public health expert, criticized the funding withdrawal, stating it puts American lives at risk and is an absurd attack on mRNA vaccines.
Importance 20.0 Sentiment 0.0
per
Donald Trump
Importance 0.0 Sentiment 0.0
cnt
United States
Importance 0.0 Sentiment 0.0
Relationships
Moderna related ↔ Robert F. Kennedy Jr.
Moderna related ↔ Donald Trump
Moderna related ↔ United States
United States — United States Department of Health and Human Services related ↔ Robert F. Kennedy Jr.
United States — United States Department of Health and Human Services related ↔ Donald Trump
United States — United States Department of Health and Human Services related ↔ United States
Robert F. Kennedy Jr. related ↔ Donald Trump
Robert F. Kennedy Jr. related ↔ United States
United States — Biomedical Advanced Research and Development Authority related ↔ United States
Donald Trump president-elect ↔ United States Donald Trump is a U.S. citizen, the 45th president, and the incoming president-elect of the United States. He is also cu
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.